life science articles and news stories

Galilaeus Oy (Ltd.)

Contact : Vice President, Marketing
Tel : TBA
Fax : TBA

Email : galilaeus@tba
Web : www.galilaeus.fi

Address :
Galilaeus Oy (Ltd.)

Finland



Galilaeus is a Contract Manufacturing and Process Development company focusing on fermentation of small molecule pharmaceuticals, also cytotoxics.

Participated at Bio/PharMOS-Bio/PharDOS 2006 

Objective : We aim to find new clients for our contract manufacturing business. We are especially interested in drug development companies that have natural products or cytotoxic compounds in their pipelines.

We also sek clients who need process development / improvement for their drug candidates.

About us : Galilaeus is a Contract Manufacturing and Process Development company specializing in small molecule pharmaceuticals, which are produced by classical fermentation, semi-synthesis or biotransformation methods.

We focus on toxic and complex compounds.

In Contract Manufacturing, Galilaeus offers fermentation manufacturing services to pharmaceutical and drug development companies. Our GMP compliant facility enables production of expensive, small volume APIs and material for preclinical and clinical studies. The site is also equipped for handling of cytotoxic APIs. We are determined to be your reliable manufacturing partner.

Galilaeus develops and commercialises proprietary bacterial strains and production processes for Active Pharmaceutical Ingredients. Our core expertise is the integration of genetic engineering technology with traditional strain improvement and fermentation techniques. This unique approach enables higher titres and simpler production processes than are available by other methods.

Our work has resulted in highly competitive processes for four, globally-used cancer therapeutics. The pipeline of production processes is constantly growing.

We provide reliable, flexible and precise service to companies looking for superior processes for APIs.

Interests

Activities



<< Back
Sign up Here for the AiLS newsletter.
08/01/2009 12:33:38